Tegaserod and Placebo
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Constipation and Dyspepsia
Conditions
Constipation and Dyspepsia
Trial Timeline
— → —
NCT ID
NCT00277550About Tegaserod and Placebo
Tegaserod and Placebo is a approved stage product being developed by Novartis for Constipation and Dyspepsia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00277550. Target conditions include Constipation and Dyspepsia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00277550 | Approved | Withdrawn |
Competing Products
20 competing products in Constipation and Dyspepsia